Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 2, 1996, Pages 401-410

  Egan, Michael F ^a   Ferguson, Jennifer ^a   Hyde, Thomas M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

habituation; haloperidol; vacuous chewing movements

Indexed keywords

HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HABITUATION; INTERMETHOD COMPARISON; INTRAMUSCULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; MASTICATION; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; RATING SCALE; TECHNIQUE;

ANIMALIA;

EID: 0030067607     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02041-1     Document Type: Article

References (34)

1. Bartko, J. J.; Carpenter, W. T. On the methods and theory of reliability. J, Nerv. Ment. Dis. 163:307-317; 1987.
2. Egan, M. F.; Hyde, T. M.; Kleinman, J. E.; Wyatt, R. J. Neuroleptic-induced vacuous chewing movements in rodents: Incidence and effects of long term increases in haloperidol dose. Psychopharmacology (Berlin) 117:74-81; 1995.
3. Ellison, G.; See, R.; Levin, E.; Kinney, J. Tremorous mouth movements in rats administered chronic neuroleptics. Psychopharmacology (Berlin) 92:122-126; 1987.
4. Gale, K. Chronic blockade of dopaine receptors by antischizophrenic drugs enhance GABA binding in substantia nigra. Nature 283:569-570; 1980.
5. Glassman, R. B.; Glassman, H. N. Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: Implications for models of tardive dyskinesia. Psychopharmacology (Berlin) 69: 19-25; 1980.
6. 6a, Glenthoj, B.; Hemmingsen, R. Intermittent neuroleptic treatment induces long-lasting mouthing in the rat. Eur. J. Pharmacol. 164:393-396; 1989.
7. Glenthoj, B.; Hemmingsen, R.; Allerup, P.; Bolwig, T. G. Intermittent vs. continuous neuroleptic treatment in a rat model. Eur. J. Pharmacol. 190:275-286; 1990.
8. Gunne, L. M.; Growden, J.; Glaeser, B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berlin) 77:134-139; 1982.
9. Gunne, L. M.; Haggstrom, J.-E. Reduction in nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology (Berlin) 81:191-194; 1983.
10. Gunne, L. M.; Andersson, U.; Bondesson, U., Johansson, P. Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav. 25:897-901; 1986.
11. Hyde, T. H.; Egan, M. F.; Kleinman, J. E. Persistent catalepsy associated with severe vacuous chewing movements in rats treated with long term haloperidol decanoate. Psychopharmacology (Berlin) 118:142-149; 1995.
12. Kaneda, H.; Shirakawa, O.; Dale, J.; Goodman, L.; Bachus, S. E.; Tamminga, C. A. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats. Eur. J. Pharmacol. 212:43-49; 1992.
13. Khot, V.; Egan, M. F.; Hyde; T. M.; Wyatt, R. J. Neuroleptics and classic tardive dyskinesia. In: Lang, A. E.; Weiner, W. J., eds. Drug-induced movement disorders. Mount Kisco, NY: Futura Publishing; 1991:121-166.
14. Levin, E. D.; Galen, D. M.; Ellison, G. D. Chronic haloperidol effects on oral movements and radial-arm maze performance in rats. Pharmacol. Biochem. Behav. 26:1-6; 1987.
15. Levy, A. D.; See, R. E.; Levin, E. D.; Ellison, G. D. Neuroleptic-induced oral movements in rats: Methodological issues. Life Sci. 41:1499-1506; 1987.
16. Mithani, S.; Atmadja, S.; Baimbridge, K. G.; Fibiger, H. C. Neuroleptic-induced oral dyskinesias: Effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology (Berlin) 93:94-100; 1987.
17. Redgrave, P.; Dean, P.; Donohoe, T. P.; Pope, S. G. Superior colliculus lesions selectively attenuate apomorphine-induced oral stereotypy: A possible role for the nigrotectal pathway. Brain Res. 196:541-546; 1980.
18. 1 mediated oral dyskinesia in rats. Life Sci. 39:29-35; 1986.
19. 1 receptors. Pharmacol. Biochem. Behav. 34:895-897; 1989.
20. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats. Psychopharmacology (Berlin) 79: 226-230; 1983.
21. Sant, W. W.; Ellison, G. Drug holidays alter onset of oral movements in rats following chronic haloperidol. Biol. Psychiatry 19: 95-99; 1984.
22. A and dopamine D-2 but not dopamine D-11 receptors. Life Sci. 44: 229-236; 1987.
23. See, R.; Ellison, G. Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats. Psychopharmacology (Berlin) 100:404-412; 1990.
24. See, R.; Ellison, G. Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur. J. Pharmacol. 181:175-186; 1990.
25. See, R.; Ellison, G. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats. J. Neural Transm. 82:93-109; 1990.
26. See, R.; Chapman, M. A. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats. Pharmacol. Biochem. and Behav. 39:49-54; 1991.
27. Steinpreis, R. E.; Baskin, P.; Salamone, J. D. Vacuous jaw movements induced by subchronic administration of haloperidol: Interactions with scopolamine. Psychopharmacology (Berlin) 111:99-105; 1993.
28. 2 receptor antagonists. Psychopharmacology (Berlin) 98:372-379; 1989.
29. Tamminga, C. A.; Dale, J. M.; Goodman, L.; Kaneda, H.; Kaneda, N. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: A study in three rat strains. Psychopharmacology (Berlin) 102:474-478; 1990.
30. Waddington, J. L.; Cross, A. J.; Gamble, S. J.; Bourne, R. C. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530-532; 1983.
31. Waddington, J. L.; Youssef, H. A.; O'Boyle, K. M.; Molloy, A. G. A reappraisal of abnormal involuntary movements (tardive dyskinesia) in schizophrenia and other disorders: Animal models and alternative hypotheses. In: Winlow, W.; Markstein, T., eds. The neurobiology of dopamine systems. Manchester: Manchester University Press; 1986:266-286.
32. Waddington, J. L.; Molloy, A. G.; O'Boyle, K. M.; Youssef, H. A. Spontaneous and drug-induced dyskinesias in rodents in relation to ageing and long-term neuroleptic treatment: Relationship to tardive dyskinesia. In: Shagass, C.; Josiassen, R. C.; Bridger, W.; Weiss, K.; Stoff, D.; Simpson, G. eds. Biological psychiatry, 1985. New York: Elsevier; 1986:1151-1153.
33. 2 dopamine receptor antagonists in young vs. aged animals. In: Sandler, M.; Dahlstrom, A.; Belmaker, R., eds. Progress in catecholamine research. Part B: Central aspects. New York: Liss; 1988:43-46.
34. Waddington, J. L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berlin) 101:431-447; 1990.